What Company Will Eli Lilly Buy Next?
Following the announced buyout of Dermira, Eli Lilly’s management said more acquisitions are in store for 2020.
SpringWorks Therapeutics Inc(SWTX)
Nasdaq Global Select
SWTX
$73.60
$0.90
1.2%
Price as of April 15, 2021, 8:00 p.m. EDT
View Interactive SWTX Charts
Interactive Chart
News & Analysis: SpringWorks Therapeutics Inc
Here's Why SpringWorks Therapeutics Climbed 69% in December
The stock climbed after investors saw encouraging signs from a similar program.
Are There Good Investments Among 2019's Biotech IPOs?
Investing in biotechs is inherently risky. IPOs are too. What does the stock performance of 2019’s biotech IPO class look like so far?
